Relationships between insulin-like growth factor i and selected clinico-morphological parameters in colorectal cancer patients

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 83, Issue 5, 2011, Pages 250-257

  Kukliński, Adam ^a   Kamocki, Zbigniew ^a   Cepowicz, Dariusz ^a   Gryko, Mariusz ^a   Czyzewska, Jolanta ^a   Pawlak, Krystyna ^a   Kȩdra, Bogusław ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

clinico morphological parameters; colorectal cancer; IGF I; surgery

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD; CANCER GRADING; CANCER STAGING; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; POLAND;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLAND;

EID: 79959745275     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-011-0039-z     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225.
2. Mandel J, Bond J, Church T, et al.: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Eng J Med 1993; 13: 1365.
3. Szymandera JJ: Kliniczne zastosowanie biochemicznych markerw nowotoworowych. Probl Med Nukl 1987; 1: 89
4. Hall K, Sara VR: Growth and Somatomedins. Vitamin. Horm., 1983; 40: 175.
5. Renehan Ag, Painter Je, O'Halloran D, et al.: Circulating Insulin-Like Growth Factor II and Colorectal Adenomas. J Clin Endocrinol Metab 2000; 85: 3402-08.
6. Duan C: Specifying the cellular responses to IGF signals: roles of IGF binding proteins. J Endocrinol 2002; 175: 41. (Pubitemid 35276585)
7. Khandwala HM, Mccutcheon IE, Flyvbjerg A, et al.: The Effects of Insulin - Like Growth Factors on Tumorigenesis and Neoplastic Growth. Endocr Rev 2000; 21: 215-44. (Pubitemid 32275588)
8. Aaronson SA: Growth factors and cancer. Science 1991; 1991: 1146. (Pubitemid 21917439)
9. Cullen KJ, Smith HS, Hill S, et al.: Growth factor messenger RNA expression by human breast fibro-blasts from benign and malignant lesions. Cancer Res 1991; 51: 4978-85.
10. Daughday WH: The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 1990; 127: 1.
11. Macaulay VM: Insulin-like growth factor and cancer. Br J Cancer 1992; 65: 311.
12. Minuto F, Del Monte P, Barreca A, et al.: Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res 1986; 46: 985-88. (Pubitemid 16145468)
13. Reeve JG, Payne JA, Bleehen NM: Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF -I binding proteins by human lung tumours. Br J Cancer 1990; 61: 727-31. (Pubitemid 20151340)
14. Stewart AJ, Johnson MD, May FE, et al.: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172-78. (Pubitemid 120014136)
15. Wu Y, Yakar S, Zhao L, et al.: Circulating insulin-like growth factor - I levels regulate colon cancer growth and metastasis. Cancer Res 2002; 15: 1030-35. (Pubitemid 34160283)
16. Lahm H, Suardet L, Laurent PL, et al.: Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 1992; 65: 341-46.
17. Manousos O, Souglakos J, Bosetti C, et al.: IGF - I and IGF - II in relation to colorectal cancer. Int J Cancer 1999; 83: 15-17.
18. Grimberg A, Cohen P: Role of Insulin - Like Growth Factor and Their Binding Proteins in Growth Control and Carcinogenesis. J Cell Physiol 2000; 183: 1-9.
19. Nomura AMY, Stemmermann GN, Lee J, et al.: Serum insulin-like growth factor and subsequent risk of colorectal cancer among Japanese-American Men. Am J Epidemiol 2003; 158: 424-31. (Pubitemid 37022840)
20. Kaaks R, Toniolo P, Akhmedkhadnov A, et al.: Serum C-peptide, insulin-like factor (IGF-I), IGF - binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600.
21. El Atiq F, Garrouste F, Remacle-Bonnet M, et al.: Alterations in serum levels of insulin-like growth factor and insulin-like growth factor binding proteins in patients with colorectal caner. Int J Cancer 1994; 57: 491-97. (Pubitemid 24173092)
22. Glass AR, Kikendall JW, Sobin LH, et al.: Serum concentrations of insulin-like growth factor I in colonic neoplasia. Acta Oncol 1994; 33: 70-71. (Pubitemid 24131691)
23. Palmqvist R, Hallmans G, Rinaldi S, et al.: Plasma insulin-like growth factor I, insulin-like growth factor binding protein 3, and risk of colorectal cancer: prospective study in northern Sweden. Gut 2002; 50: 642-46. (Pubitemid 34407490)
24. Probst-Hensch NM, Yuan JM, Stanczyk FZ, et al.: IGF I, IGF II and IGF BP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Brit J Cancer 2001; 85: 1695-99. (Pubitemid 34081515)
25. Ma J, Pollak MN, Giovannucci E, et al.: Prospectivestudy of colorectal cancer risk in men and plasma levels of insulin-like gowth factor (IGF) - I and binding protein-3. J Natl Cancer Inst 1999; 91: 620-25. (Pubitemid 29194048)
26. Renehan AG, Painter JE, Atkin WS, et al.: High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 2001; 88: 107-13. (Pubitemid 32066068)
27. Teramukai S, Rohan T, Lee KY, et al.: Insulin-like growth factor (IGF)- I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Jpn J Cancer Res 2002; 93: 1187-94. (Pubitemid 36032980)
28. Hassan AB, Macaulau VM: The insulin-like growth factor system as a therapeutic target in colorectal cancer. Ann Oncol 2002; 13: 349-56.
29. Wei EK, Ma J, Pollak MN, et al.: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-I, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005; 14: 850-55. (Pubitemid 40478547)
30. Ma J, Giovannucci E, Pollak M, et al.: A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 546-53. (Pubitemid 38559579)
31. Clemmons DR, Underwood LE, Ridgway EC, et al.: Estradiol treatment of acromegaly, Rduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med 1980; 69: 571-75. (Pubitemid 10018713)
32. Michell NP, Langman MJS, Eggo MC, et al.: Insulin-like growth factor and their binding proteins in human colonocytes. Preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer 1997; 76: 60-66.
33. Bauer TW, Fan F, Liu W, et al.: Insulinlike growth factor I mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Ann Surg 2005; 241: 748-56.